AIP
BMRA icon

Ahrens Investment Partners’s Biomerica BMRA Stock Holding History

Ahrens Investment Partners’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13
Closed – – 251
2022
Q2 		$0 Hold
13
– – ﹤0.01% 965
2022
Q1 		$0 Hold
13
– – ﹤0.01% 1031
2021
Q4 		$0 Buy
+13
New +$501 ﹤0.01% 1032

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.29B AUM 26.44% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $244M AUM
FC
Fore Capital New York $162M AUM 14.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ahrens Investment Partners's BMRA Position: Q3 2022 in Review

Ahrens Investment Partners sold out of Biomerica (BMRA) in Q3 2022, closing a stake of 13 shares.

Ahrens Investment Partners first reported a position in BMRA in Q4 2021 and held it in 3 quarters. The position peaked at $0 in Q2 2022. 31 funds tracked by Wall St. Rank hold BMRA as of Q3 2022.

  • Ahrens Investment Partners reported no remaining Biomerica position as of Q3 2022 after selling out during the quarter.
  • Ahrens Investment Partners sold 13 Biomerica shares in Q3 2022.
  • Ahrens Investment Partners first reported a position in Biomerica in Q4 2021 and held it in 3 quarters.
  • Ahrens Investment Partners's Biomerica position peaked at $0 in Q2 2022.
  • 31 funds tracked by Wall St. Rank held Biomerica as of Q3 2022.

Based on Ahrens Investment Partners's 13F filing for Q3 2022, filed 8 Nov 2022.